Filing Details
- Accession Number:
- 0000950170-25-029332
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-27 18:53:01
- Reporting Period:
- 2025-02-25
- Filing Date:
- 2025-02-27
- Accepted Time:
- 2025-02-27 18:53:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1984086 | Septerna Inc. | SEPN | Pharmaceutical Preparations (2834) | 843891440 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2040376 | Jeffrey Finer | Septerna, Inc. 250 East Grand Avenue South San Francisco CA 94080 | Ceo And President | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-25 | 10,000 | $5.68 | 764,907 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-02-26 | 4,000 | $5.70 | 768,907 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2025-02-27 | 3,000 | $5.80 | 771,907 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.55 to $5.74. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.695 to $5.71. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Billionaire Hedge Funds
